Koyfin Home > Directory > Health Care > Acceleron Pharma > Return on Capital %

Acceleron Pharma Return on Capital % Chart (XLRN)

Acceleron Pharma annual/quarterly Return on Capital % from 2013 to 2020.
  • Acceleron Pharma Return on Capital % for the quarter ending June 06, 2020 was -10.70 a -123.76% increase of 13.24 year over year
  • Acceleron Pharma Return on Capital % for the last 12 months ending June 06, 2020 was -18.61 a -22.22% increase of 4.13 year over year
  • Acceleron Pharma Annual Return on Capital % for 2019 was -22.21 a -6.53% increase of 1.45 from 2018
  • Acceleron Pharma Annual Return on Capital % for 2018 was -23.66 a 1.66% decrease of -0.39 from 2017
  • Acceleron Pharma Annual Return on Capital % for 2017 was -23.27 a -6.05% increase of 1.41 from 2016
Other Margins & Efficiency Metrics:
  • Acceleron Pharma EBITDA Margin for the quarter ending March 03, 2016 was $-20m a -39.99% increase of 8m year over year
  • Acceleron Pharma Return on Equity % for the quarter ending September 09, 2018 was -35.54 a 13.15% decrease of -4.68 year over year
View Chart On Koyfin

Quarterly XLRN Return on Capital % Data

06/2020-10.70
03/2020-28.19
12/2019-13.21
09/2019-23.94
06/2019-9.88
03/2019-24.49
12/2018-30.11
09/2018-23.05
06/2018-21.77
03/2018-19.22

Annual XLRN Return on Capital % Data

2019-22.21
2018-23.66
2017-23.27
2016-24.68
2015-28.66
2014-27.31
201311.75
2012-238.31